(Q39912694)

15 September 2017

Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo (English)

1 reference

15 September 2017

0 references

1 reference

1 reference

7

Geert Leroux-Roels

0 references

Thomas Vanwolleghem

4

object named as

Thomas Vanwolleghem

1 reference

15 September 2017

5

Isabelle Desombere

1 reference

15 September 2017

Philip Meuleman

1

1 reference

15 September 2017

Joseph Hesselgesser

2

1 reference

15 September 2017

Matthew Paulson

3

1 reference

15 September 2017

Hans Reiser

6

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

15 September 2017

1 reference

15 September 2017

48

1 reference

15 September 2017

6

1 reference

15 September 2017

1761-1768

1 reference

Binding of hepatitis C virus to CD81

15 September 2017

1 reference

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

21 January 2018

1 reference

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

21 January 2018

1 reference

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

21 January 2018

1 reference

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

21 January 2018

1 reference

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.

21 January 2018

1 reference

Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization

21 January 2018

1 reference

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

21 January 2018

1 reference

Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity

21 January 2018

1 reference

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

21 January 2018

1 reference

L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus

21 January 2018

1 reference

C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles

21 January 2018

1 reference

L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

21 January 2018

1 reference

Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor

21 January 2018

1 reference

Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate

21 January 2018

1 reference

Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses

21 January 2018

1 reference

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

21 January 2018

1 reference

Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection

21 January 2018

1 reference

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

21 January 2018

1 reference

Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent

21 January 2018

1 reference

Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene

21 January 2018

1 reference

Near completely humanized liver in mice shows human-type metabolic responses to drugs

21 January 2018

1 reference

Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera

21 January 2018

1 reference

Hepatitis C virus replication in mice with chimeric human livers

21 January 2018

1 reference

Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication

21 January 2018

1 reference

A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice.

21 January 2018

1 reference

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

21 January 2018

1 reference

CD81 is an entry coreceptor for hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus kinetics during and immediately after liver transplantation.

21 January 2018

1 reference

Hepatitis B and hepatitis C viruses in liver transplantation

21 January 2018

1 reference

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

21 January 2018

1 reference

A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry

21 January 2018

1 reference

Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81

21 January 2018

1 reference

Expression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 Binding

21 January 2018

1 reference

Small molecule inhibition of hepatitis C virus E2 binding to CD81

21 January 2018

1 reference

Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.

21 January 2018

1 reference

Phage display selection on whole cells yields a small peptide specific for HCV receptor human CD81.

21 January 2018

1 reference

Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81.

21 January 2018

1 reference

High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein

21 January 2018

1 reference

Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity

21 January 2018

1 reference

Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species

21 January 2018

1 reference

Hepatitis C and liver transplantation

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.22547

1 reference

15 September 2017

1 reference